| Bioactivity | D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. D[LEU4,LYS8]-VP TFA has weak antidiuretic, vasopressor, and in vitro oxytocic activities[1][2]. | ||||||
| Name | D[LEU4,LYS8]-VP TFA | ||||||
| Sequence | {Mpa}-Tyr-Phe-Leu-Asn-Cys-Pro-Lys-Gly (Disulfide bridge:Mpa1-Cys6) | ||||||
| Shortening | {Mpa}-YFLNCPKG-NH2 (Disulfide bridge:Mpa1-Cys6) | ||||||
| Formula | C49H68F3N11O13S2 | ||||||
| Molar Mass | 1140.25 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
D[LEU4,LYS8]-VP TFA
CAS: F: C49H68F3N11O13S2 W: 1140.25
D-VP TFA is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, hu
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.